Stagno F - Search Results

1

First-hit SETBP1 mutations cause a myeloproliferative disorder with bone marrow fibrosis.

Crespiatico I, Zaghi M, Mastini C, D'Aliberti D, Mauri M, Mercado CM, Fontana D, Spinelli S, Crippa V, Inzoli E, Manghisi B, Civettini I, Ramazzotti D, Sangiorgio V, Gengotti M, Brambilla V, Aroldi A, Banfi F, Barone C, Orsenigo R, Riera L, Riminucci M, Corsi A, Breccia M, Morotti A, Cilloni D, Roccaro A, Sacco A, Stagno F, Serafini M, Mottadelli F, Cazzaniga G, Pagni F, Chiarle R, Azzoni E, Sessa A, Gambacorti-Passerini C, Elli EM, Mologni L, Piazza R. Crespiatico I, et al. Among authors: stagno f. Blood. 2024 Apr 4;143(14):1399-1413. doi: 10.1182/blood.2023021349. Blood. 2024. PMID: 38194688

2

Sequential mutations causing resistance to both Imatinib Mesylate and Dasatinib in a chronic myeloid leukaemia patient progressing to lymphoid blast crisis.

Stagno F, Stella S, Berretta S, Massimino M, Antolino A, Giustolisi R, Messina A, Di Raimondo F, Vigneri P. Stagno F, et al. Leuk Res. 2008 Apr;32(4):673-4. doi: 10.1016/j.leukres.2007.08.008. Epub 2007 Sep 24. Leuk Res. 2008. PMID: 17889935 No abstract available.

3

Vitro drug-induced apoptosis in freshly isolated leukemic cells: a flow cytometric analysis.

Stagno F, Impera S, Italia P, Corsaro F, Cacciola E Jr, Guglielmo P. Stagno F, et al. Boll Soc Ital Biol Sper. 1995 Mar-Apr;71(3-4):99-104. Boll Soc Ital Biol Sper. 1995. PMID: 7646876

4

Multidrug resistance mechanisms in chronic lymphocytic leukaemia.

Consoli U, Santonocito A, Stagno F, Fiumara P, Privitera A, Parisi G, Giustolisi GM, Pavone B, Palumbo GA, Di Raimondo F, Milone G, Guglielmo P, Giustolisi R. Consoli U, et al. Among authors: stagno f. Br J Haematol. 2002 Mar;116(4):774-80. doi: 10.1046/j.0007-1048.2002.03344.x. Br J Haematol. 2002. PMID: 11886380 Free article.

5

T cell receptor delta-chain gene rearrangement in a novel case of adult NK cell leukemia.

Stagno F, Guglielmo P, Lo Nigro L, Santonocito A, Giustolisi R. Stagno F, et al. Acta Haematol. 2004;111(4):225-7. doi: 10.1159/000077571. Acta Haematol. 2004. PMID: 15153716

6

All-trans retinoic acid might also induce apoptosis in freshly isolated chronic myeloid leukemia cells.

Stagno F, Consoli U, Cacciola E Jr. Stagno F, et al. Haematologica. 1997 Jan-Feb;82(1):125. Haematologica. 1997. PMID: 9107100 No abstract available.

7

Aberrant phenotypic expression of the T-cell-associated antigen CD8 on B-cell chronic lymphocytic leukemia cells.

Stagno F, Triolo A, Del Fabro V, Berretta S, Parrinello NL, Fargione G, Di Raimondo F. Stagno F, et al. Lab Hematol. 2009;15(1):1-3. doi: 10.1532/LH96.08015. Lab Hematol. 2009. PMID: 19273392

8

Imatinib dose escalation to achieve molecular responses in patients with chronic myeloid leukemia in late chronic phase.

Stagno F, Vigneri P, Del Fabro V, Stella S, Massimino M, Berretta S, Messina A, Di Raimondo F. Stagno F, et al. Leuk Res. 2009 Jun;33(6):e17. doi: 10.1016/j.leukres.2008.10.015. Epub 2008 Nov 25. Leuk Res. 2009. PMID: 19036439 No abstract available.

9

VLA-4 and VLA-5 integrin expression in adult acute lymphoblastic leukemia.

Stagno F, Cacciola E, Guglielmo P, Cacciola RR, Cacciola E. Stagno F, et al. Exp Hematol. 1996 Mar;24(4):493. Exp Hematol. 1996. PMID: 8608797 No abstract available.

10

IRF5 is a target of BCR-ABL kinase activity and reduces CML cell proliferation.

Massimino M, Consoli ML, Mesuraca M, Stagno F, Tirrò E, Stella S, Pennisi MS, Romano C, Buffa P, Bond HM, Morrone G, Sciacca L, Di Raimondo F, Manzella L, Vigneri P. Massimino M, et al. Among authors: stagno f. Carcinogenesis. 2014 May;35(5):1132-43. doi: 10.1093/carcin/bgu013. Epub 2014 Jan 20. Carcinogenesis. 2014. PMID: 24445143

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

153 results

Search Page